Prevention of ventilator associated pneumonia. Evaluation of the cost-benefit of the current strategies;Prevención de la asociada a la ventilación mecánica. Evaluación del coste-beneficio de las estrategias actuales

Medicina Clinica

Volumn 115, Issue 13, 2000, Pages 510-515

  Ferrer Roca, Ricard ^b   Bauer, Torsten ^c   Torres Martí, Antoni ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; RECOMBINANT CYTOKINE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANTIBIOTIC PROPHYLAXIS; ARTIFICIAL VENTILATION; COST BENEFIT ANALYSIS; CYTOKINE PRODUCTION; DISINFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INFECTION COMPLICATION; PNEUMONIA; REVIEW; STOMACH DISTENSION;

EID: 0034699729     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(00)71607-1     Document Type: Review

References (79)

1. Hospital-acquired pneumonia in adults: Diagnosis, assessment, initial therapy, and prevention: A consensus statement
2. Pneumonia in an intensive care unit
3. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques
4. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
5. Nosocomial infection and fatality in medical and surgical intensive care unit patients
6. Colonization and infection in surgical intensive care patients
7. Hospital acquired infections surveillance and control in intensive care services. Results of an incidence study
8. Risk factors for pneumonia and fatality in patients receiving mechanical ventilation
9. Ventilator-associated pneumonia: A multivariate analysis
10. Hight cost nosocomial infection
11. Prospective payment and infection control
12. Pneumonia in intubated trauma patients. Microbiology and outcomes
13. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality
14. Incidence and etiology of pneumonia acquired during mechanical ventilation
15. Hospital-acquired pneumonia. Attributable mortality and morbidity
16. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
17. Guideline for prevention of nosocomial pneumonia
18. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units
19. Nosocomial pneumonia: A multivariate analysis of risk and prognosis
20. Nosocomial respiratory tract infections in multiple trauma patients. Influence of level of consciousness with implications for therapy
21. A predictive index for nosocomial pneumonia in the intensive care unit
22. Nosocomial pneumonia and thacheitis in a pediatric intensive care unit: A prospective study
23. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria
24. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia
25. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position
26. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients
27. Nosocomial infection in an intensive-care unit: Identification of risk factors
28. Supine body position is a risk factor of nosocomial pneumonia in mechanically ventilated patients: A randomised clinical trial
29. Gastroduodenal dysfunction and bacterial colonisation of the ventilated lung
30. Epidemiology of nosocomial pneumonia: New concepts on an old disease
31. Pneumonia in intubated patients: Role of respiratory airway care
32. Risk factors and clinical relevance of nosocomial maxillary sinisitis in the critically ill
33. Re-intubation increases the risk of nosocomial pneumonia in patients needing mechanical ventilation
34. Reduction of nosocomial infection during pediatric intensive care by protective isolation
35. Clorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery
36. Significant reduction in methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia associated with the institution of a prevention control
37. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma
38. The stomach is not a source for colonization of the upper respiratory tract and pneumonia n ICU patients
39. Pattern of tracheal colonization during mechanical ventilation
40. Role of gastric colonization in nosocomial infections and endotoxemia: A prospective study in neurosurgical patients on mechanical ventilation
41. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer
42. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury
43. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: A randomized, controlled trial
44. Continuous intravenous cimetidine decreases stress-related gastrointestinal hemorrhage without promoting pneumonia
45. Impact of multiple risk factors and ranitidine prophylaxis on the development of stress-related gastrointestinal bleeding: A prospective, multicenter, double-blind randomized trial
46. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiting mechanical ventilation
47. Large volume gastroesophageal reflux: A rational for risk reduction in the perioperative period
48. Severe pneumonia: Sources of infection and implications for treatment
49. Gastro-esophgeal reflux and microaspiration to lower airways in intubated patients: Impact of nasogastric tube size
50. Risk factors for nosocomial pneumonia in the elderly
51. Enteral nutrition in the critically ill patient: A critical review of the evidence
52. Nutritional outcome and pneumoma in critical care patients radomized to gastric versus jejunal tube feedings
53. Early enteral administration of a formula (impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: Results of a multicenter, prospective, randomized trial
54. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey
55. Noninvasive mechanical ventilation in the weaning of patients with respiration failure due to chronic obstructive pulmonary disease. A randomized controlled trial
56. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
57. Prevention of nosocomial pneumonia in intubated patients: Respective role of mechanical sugglottic secretions drainage and stress ulcer prophylaxis
58. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
59. Prolonged use of ventilator circuits and ventilator-associated pneumonia: A model for identifying clinical practice
60. A prospective randomized comparison of an in-line heat moisture exchang filter and heated wire humidifiers: Rates of ventilator-associated early-onset (community-acquired) or late-onset (hospital-acquired) pneumonia and incidence of endotracheal tube occlusion
61. Nosocomial legionnaires' disease and use of medication nebulizers
62. Factors contributing to the contamination of hospital water distribution systems by Legionellae
63. Decrease in nosocomial pneumonia in ventilated patients by selective oropharyngeal decontamination
64. Effect of selective decontamination of the digestive tract on respiratory tract infections and modality in the intensive care unit
65. Prevention of infection in critically ill patients by selective decontamination of the digestive tract
66. Utility of selective digestive decontamination in mechanically ventilated patients
67. A randomized, double-blind, placebo-controled trial of selective digestive decontamination in a medical-surgical intensive care unit
68. Double-blind study of selective decontamination of the digestive tract in intensive care
69. Effectiveness of antibiotic prophylaxis in critically ill adult patients
70. A controled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics
71. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients. A randomized, double-blind, placebo-controlled, multicenter trial
72. Effect of air-supported, continuous, postural oscillation on the risk of early ICU pneumonia in nontraumatic critical illness
73. Kinetic therapy in critically ill trauma patients
74. Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection
75. Filgastrim in patients with chemotherapy-induced febrile neutropenia: A double-blind, placebo-controlled trial
76. Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgastrim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral haemorrhage
77. Monocyte deactivation in septic patients: Restoration by INF-gamma treatment
78. Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial
79. IL-12 gene therapy protects mice in lethal Klebsiella pneumonia